Kee-Hong Kim, Ph.D.

Dr. Kim joined Tenaya in 2018 to serve as Senior Vice President of Technical Operations. During his tenure, he has led the company’s effort to internalize process development, analytical development and quality control capabilities, and overseen the establishment of Tenaya’s cGMP manufacturing facility. Prior to joining Tenaya, Dr. Kim was Senior Vice President, Head of Technical Operations at Agilis Biotherapeutics, where he had accountability for manufacturing of gene therapy drug products and establishing reliable clinical and commercial supply chains.

Prior to that, he was the Head of Gene Therapy Process Development and the Global CMC Lead of Gene Therapy at Shire. Dr. Kim also ran his own biopharma consulting firm, which he started after serving as Director of Process Development at Avalanche Biotechnology (now Adverum). Dr. Kim was responsible for the process development, manufacturing science and related regulatory filings for Dendreon’s commercial product PROVENGE™. Earlier in his career, Dr. Kim had roles of increasing leadership at several technical organizations including Aeras TB Foundation and Walter Reed Army Medical Center. He completed his post-doctoral training at Cornell University and received his doctoral degree in chemical engineering from Colorado State University.